Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials
Authors:
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 31 (9) , 621-629
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experienceRadiation Oncology, 2013
- Radiotherapy Doses of 80 Gy and Higher Are Associated With Lower Mortality in Men With Gleason Score 8 to 10 Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrenceRadiation Oncology, 2012
- Evaluating the Phoenix Definition of Biochemical Failure After 125I Prostate Brachytherapy: Can PSA Kinetics Distinguish PSA Failures From PSA Bounces?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivationBrachytherapy, 2010
- Prostate-specific Antigen Bounce After Prostate Brachytherapy: Review of a Confusing PhenomenonUrology, 2009
- An Eight-Year Experience of HDR Brachytherapy Boost for Localized Prostate Cancer: Biopsy and PSA OutcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- PSA Kinetics and PSA Bounce Following Permanent Seed Prostate BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Biochemical and clinical significance of the posttreatment prostate‐specific antigen bounce for prostate cancer patients treated with external beam radiation therapy aloneCancer, 2006
- Temporal effect of neoadjuvant androgen deprivation therapy on PSA kinetics following permanent prostate brachytherapy with or without supplemental external beam radiationBrachytherapy, 2004